Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)

被引：66

作者：

Demeter, LM

Shafer, RW

Meehan, PM

Holden-Wiltse, J

Fischl, MA

Freimuth, WW

Para, MF

Reichman, RC

机构：

[1] Univ Rochester, Infect Dis Unit, Sch Med & Dent, Rochester, NY 14642 USA

[2] Stanford Univ, Palo Alto, CA 94304 USA

[3] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA

[4] Univ Miami, Miami, FL 33152 USA

[5] Pharmacia & Upjohn Inc, Kalamazoo, MI 49001 USA

[6] Ohio State Univ, Columbus, OH 43210 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2000年 / 44卷 / 03期

关键词：

D O I：

10.1128/AAC.44.3.794-797.2000

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

The development of human immunodeficiency virus type 1 resistance to delavirdine (DLV) was studied in subjects receiving DLV monotherapy. Phenotypic resistance developed in 28 of 30 subjects within 8 weeks. K103N and Y181C, which confer nonnucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance, were the predominant reverse transcriptase mutations. P236L, which confers DLV resistance but hypersensitivity to other NNRTIs, developed in <10% of isolates.

引用

页码：794 / 797

页数：4

共 20 条

[1] COMPREHENSIVE MUTANT ENZYME AND VIRAL VARIANT ASSESSMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE RESISTANCE TO NONNUCLEOSIDE INHIBITORS
BYRNES, VW
SARDANA, VV
SCHLEIF, WA
CONDRA, JH
WATERBURY, JA
WOLFGANG, JA
LONG, WJ
SCHNEIDER, CL
SCHLABACH, AJ
WOLANSKI, BS
GRAHAM, DJ
GOTLIB, L
RHODES, A
TITUS, DL
ROTH, E
BLAHY, OM
QUINTERO, JC
STASZEWSKI, S
EMINI, EA
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1576 - 1579
[2] DeClercq E, 1996, MED RES REV, V16, P125, DOI 10.1002/(SICI)1098-1128(199603)16:2<125::AID-MED1>3.0.CO
[3] 2-2
[4] HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delaviridine
Demeter, LM
Meehan, PM
Morse, G
Gerondelis, P
Dexter, A
Berrios, L
Cox, S
Freimuth, W
Reichman, RC
[J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1997, 14 (02): : 136 - 144
[5] U-90152, A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION
DUEWEKE, TJ
POPPE, SM
ROMERO, DL
SWANEY, SM
SO, AG
DOWNEY, KM
ALTHAUS, IW
REUSSER, F
BUSSO, M
RESNICK, L
MAYERS, DI
LANE, J
ARISTOFF, PA
THOMAS, RC
TARPLEY, WG
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) : 1127 - 1131
[6] A MUTATION IN REVERSE-TRANSCRIPTASE OF BIS(HETEROARYL)PIPERAZINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 THAT CONFERS INCREASED SENSITIVITY TO OTHER NONNUCLEOSIDE INHIBITORS
DUEWEKE, TJ
PUSHKARSKAYA, T
POPPE, SM
SWANEY, SM
ZHAO, JQ
CHEN, ISY
STEVENSON, M
TARPLEY, WG
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (10) : 4713 - 4717
[7] Unique features in the structure of the complex between HIV-1 reverse transcriptase and the bis(heteroaryl)piperazine (BHAP) U-90152 explain resistance mutations for this nonnucleoside inhibitor
Esnouf, RM
Ren, JS
Hopkins, AL
Ross, CK
Jones, EY
Stammers, DK
Stuart, DI
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (08) : 3984 - 3989
[8] The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5′-end- and DNA 3′-end-directed RNase H activities
Gerondelis, P
Archer, RH
Palaniappan, C
Reichman, RC
Fay, PJ
Bambara, RA
Demeter, LM
[J]. JOURNAL OF VIROLOGY, 1999, 73 (07) : 5803 - 5813
[9] STANDARDIZATION OF SENSITIVE HUMAN-IMMUNODEFICIENCY-VIRUS COCULTURE PROCEDURES AND ESTABLISHMENT OF A MULTICENTER QUALITY ASSURANCE PROGRAM FOR THE AIDS CLINICAL-TRIALS GROUP
HOLLINGER, FB
BREMER, JW
MYERS, LE
GOLD, JWM
MCQUAY, L
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (07) : 1787 - 1794
[10] STANDARDIZED MICROTITER ASSAY FOR DETERMINATION OF SYNCYTIUM-INDUCING PHENOTYPES OF CLINICAL HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ISOLATES
JAPOUR, AJ
FISCUS, SA
ARDUINO, JM
MAYERS, DL
REICHELDERFER, PS
KURITZKES, DR
[J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (09) : 2291 - 2294

← 1 2 →